Ulcerative colitis is a chronic, relapsing–remitting, non-infectious inflammatory disease of the gastrointestinal tract. The aim of treatment is to reduce symptoms and maintain or improve quality of life.
In the UK, ulcerative colitis has an incidence of approximately 10 per 100,000 people annually. Ulcerative Colitis; NICE Clinical Guideline (Jun 2013)
Dispensed volumes of the target drug increased in active pharmacies during and after the initial two-month pilot patient support programme.
Three programme extensions, during which clinical message alerts reinforced the message that patients could take their six doses at the same time each day, maintained the positive impact on dispensed volumes, suggesting the patient support programme had a significant impact on medication compliance.